"Semaglutide and Tirzepatide in Patients With Heart Failure With Preserved Ejection Fraction"
It's biology protecting you from what it perceives as scarcity
Gastrointestinal side effects, including nausea, constipation, diarrhea, and vomiting, were the most common complaint in both groups and were generally mild to moderate, occurring mostly during the dose escalation phase.[1] Injection site reactions were more common with tirzepatide (8.6% vs
This physical delay is a primary mechanism for the early feelings of fullness
Changes in Blood Sugar While semaglutide is famously touted as a weight loss drug, it can also help with blood sugar control, thanks to GLP-1s role in regulating blood glucose levels
With an even higher hazard ratio than that of the type 2 diabetes group, the analysis again showed a higher risk of NAION for patients on semaglutide who were overweight or obese (hazard ratio: 7.64)